Thread by @sarahhudsonuk

💥My top 10 learning points from the #ESCCongress💥

A thread for cardiologists/general physicians

1) Post acute MI, transfuse if ≤8g/dL

Evidence: REALITY trial- not yet published – summary reported acc.org/latest-in-card…

1/n

2) SGLT2i in addition to standard HF treatment significantly ⬇️CV death, including in non-diabetic pts

Evidence: EMPEROR-Reduced (nejm.org/doi/full/10.10…)
& metanalysis of DAPA-HF and EMPEROR-Reduced (thelancet.com/journals/lance…)

#ESCCongress
2/n

3) Colchicine 0.5mg od in pts with chronic coronary disease⬇️CV death/MI/CVA

Evidence: LoDoCo 2 -nejm.org/doi/full/10.10…

#ESCCongress

3/n

4) Dapagliflozin in pts with CKD, with or without T2DM, significantly ⬇️risk of kidney failure, CV death and HF hospitalisation

Evidence: DAPA CKD – not yet published - escardio.org/The-ESC/Press-…

#ESCCongress

4/n

5) Digoxin could be considered as a first-line approach for rate control in older adults with AF

Evidence: RATE-AF – not yet published - cardiacrhythmnews.com/esc-2020-congr…

#ESCCongress

5/n

6) There is a new treatment option for HOCM – mavacamten

Evidence: EXPLORER-HCM - thelancet.com/journals/lance…

#ESCCongress

6/n

7) No need to stop ACEi/ARB in COVID pts

Evidence: BRACE CORONA - not yet published - escardio.org/The-ESC/Press-…

#ESCCongress

7/n

8) Early rhythm control decreases risk of adverse cardiovascular outcomes in AF

Evidence: EAST AFNET 4 nejm.org/doi/full/10.10…

#ESCCongress

8/n

9)Post TAVI, aspirin alone is a better strategy than aspirin and clopidogrel

Evidence: POPULAR TAVI nejm.org/doi/full/10.10…

#ESCCongress

9/n

10) Either the sPESI or the HESTIA score can be used to identify ~ a third of pts with PE who can be discharged early and treated at home

Evidence: HOME PE - not yet published - escardio.org/The-ESC/Press-…

#ESCCongress

10/10